Robert Wolkow

1.6k total citations
23 papers, 1.1k citations indexed

About

Robert Wolkow is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, Robert Wolkow has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Psychology, 13 papers in Experimental and Cognitive Psychology and 8 papers in Cognitive Neuroscience. Recurrent topics in Robert Wolkow's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Robert Wolkow is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Robert Wolkow collaborates with scholars based in United States. Robert Wolkow's co-authors include Cathryn M. Clary, Joseph Biederman, John S. March, Edwin H. Cook, Karen Dineen Wagner, James M. Ferguson, Jack Mardekian, Elizabeth Hackett, Arkady Rubin and Jeffrey Alderman and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Robert Wolkow

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Wolkow United States 13 795 543 389 243 220 23 1.1k
Cornelius D. Pitts United States 11 530 0.7× 512 0.9× 479 1.2× 127 0.5× 490 2.2× 14 1.3k
Suzanne M. Sutherland United States 12 677 0.9× 297 0.5× 303 0.8× 129 0.5× 289 1.3× 16 1.1k
Joseph Deltito United States 20 347 0.4× 351 0.6× 408 1.0× 100 0.4× 224 1.0× 34 962
Gopinath Mallya United States 11 666 0.8× 276 0.5× 863 2.2× 114 0.5× 202 0.9× 16 1.4k
Vito Agosti United States 20 348 0.4× 270 0.5× 364 0.9× 120 0.5× 466 2.1× 35 1.1k
T. Sivakumaran United Kingdom 14 411 0.5× 208 0.4× 230 0.6× 183 0.8× 135 0.6× 25 763
Jovan Simeon Canada 16 579 0.7× 206 0.4× 616 1.6× 209 0.9× 125 0.6× 46 1.0k
H. Bruce Ferguson Canada 13 505 0.6× 211 0.4× 476 1.2× 145 0.6× 97 0.4× 26 944
T. Bronisch Germany 17 687 0.9× 230 0.4× 323 0.8× 127 0.5× 138 0.6× 54 1.2k
J.D. Guelfi France 17 473 0.6× 206 0.4× 506 1.3× 88 0.4× 353 1.6× 55 1.1k

Countries citing papers authored by Robert Wolkow

Since Specialization
Citations

This map shows the geographic impact of Robert Wolkow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wolkow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wolkow more than expected).

Fields of papers citing papers by Robert Wolkow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Wolkow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wolkow. The network helps show where Robert Wolkow may publish in the future.

Co-authorship network of co-authors of Robert Wolkow

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Wolkow. A scholar is included among the top collaborators of Robert Wolkow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Wolkow. Robert Wolkow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alderman, Jeffrey, et al.. (2006). Drug Concentration Monitoring with Tolerability and Efficacy Assessments during Open-Label, Long-Term Sertraline Treatment of Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 117–129. 14 indexed citations
2.
Hackett, Elizabeth, et al.. (2002). Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder. American Journal of Psychiatry. 159(1). 88–95. 93 indexed citations
3.
Cook, Edwin H., et al.. (2002). Long-term sertraline treatment for pediatric OCD: remission rates and functional status. European Psychiatry. 17. 116–116. 1 indexed citations
4.
Rapaport, Mark Hyman, Robert Wolkow, Arkady Rubin, et al.. (2001). Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatrica Scandinavica. 104(4). 289–298. 51 indexed citations
5.
Rapaport, Mark Hyman, Mark H. Pollack, Cathryn M. Clary, Jack Mardekian, & Robert Wolkow. (2001). Panic Disorder and Response to Sertraline: The Effect of Previous Treatment with Benzodiazepines. Journal of Clinical Psychopharmacology. 21(1). 104–107. 3 indexed citations
6.
Cook, Edwin H., Karen Dineen Wagner, John S. March, et al.. (2001). Long-Term Sertraline Treatment of Children and Adolescents With Obsessive-Compulsive Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 40(10). 1175–1181. 108 indexed citations
7.
Rapaport, Mark Hyman, Robert Wolkow, Arkady Rubin, et al.. (2001). Sertraline treatment of panic disorder: results of a long‐term study. Acta Psychiatrica Scandinavica. 104(4). 289–298. 15 indexed citations
8.
Rapaport, Mark Hyman, Mark H. Pollack, Robert Wolkow, Jack Mardekian, & Cathryn M. Clary. (2000). Is Placebo Response the Same as Drug Response in Panic Disorder?. American Journal of Psychiatry. 157(6). 1014–1016. 39 indexed citations
9.
Wilens, Timothy E., Joseph Biederman, John S. March, et al.. (1999). Absence of Cardiovascular Adverse Effects of Sertraline in Children and Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 38(5). 573–577. 25 indexed citations
10.
Alderman, Jeffrey, Robert Wolkow, Menger Chung, & Hugh F. Johnston. (1998). Sertraline Treatment of Children and Adolescents With Obsessive‐Compulsive Disorder or Depression: Pharmacokinetics, Tolerability, and Efficacy. Journal of the American Academy of Child & Adolescent Psychiatry. 37(4). 386–394. 93 indexed citations
11.
March, John S., Joseph Biederman, Robert Wolkow, et al.. (1998). Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder. JAMA. 280(20). 1752–1752. 322 indexed citations
12.
Londborg, Peter D., Robert Wolkow, Ward T. Smith, et al.. (1998). Sertraline in the treatment of panic disorder. The British Journal of Psychiatry. 173(1). 54–60. 105 indexed citations
13.
Wolkow, Robert, et al.. (1998). Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial. American Journal of Psychiatry. 155(9). 1189–1195. 105 indexed citations
14.
Pollack, Mark H., Michael W. Otto, John J. Worthington, Gisele Gus Manfro, & Robert Wolkow. (1998). Sertraline in the Treatment of Panic Disorder. Archives of General Psychiatry. 55(11). 1010–1010. 113 indexed citations
15.
Pollack, Mark H., Cathryn M. Clary, Robert Wolkow, et al.. (1998). Early response to sertraline as a predictor of 12-week outcome in panic disorder. European Neuropsychopharmacology. 8. S257–S257. 1 indexed citations
16.
Pohl, Robert, Cathryn M. Clary, & Robert Wolkow. (1997). Sertraline treatment of panic disorder: Combined results from two placebo-controlled trials. Biological Psychiatry. 42(1). 28S–28S. 1 indexed citations
17.
Wolkow, Robert, John S. March, Allan Z. Safferman, & Joseph Biederman. (1997). A placebo-controlled trial of sertraline treatment for pediatric obsessive compulsive disorder. Biological Psychiatry. 42(1). 213S–214S. 4 indexed citations
18.
Pollack, Mark H., Robert Wolkow, & Cathryn M. Clary. (1997). Multi-dimensional outcome and quality of life in panic disorder: The effects of sertraline treatment. Biological Psychiatry. 42(1). 248S–248S. 1 indexed citations
19.
Bielski, Robert J., John Scott Carman, Wayne K. Goodman, et al.. (1996). Double-blind comparison of sertraline and placebo in patients with panic disorder. European Neuropsychopharmacology. 6. 112–113. 2 indexed citations
20.
DuBoff, E., et al.. (1995). P-2-37 Double-blind comparison of three fixed doses of sertraline and placebo in patients with panic disorder. European Neuropsychopharmacology. 5(3). 287–287. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelius D. Pitts Breakdown of academic impact, for papers by Suzanne M. Sutherland Breakdown of academic impact, for papers by Joseph Deltito Breakdown of academic impact, for papers by Gopinath Mallya Breakdown of academic impact, for papers by Vito Agosti Breakdown of academic impact, for papers by T. Sivakumaran Breakdown of academic impact, for papers by Jovan Simeon Breakdown of academic impact, for papers by H. Bruce Ferguson Breakdown of academic impact, for papers by T. Bronisch Breakdown of academic impact, for papers by J.D. Guelfi
Rankless by CCL
2026